ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Performance evaluation of the BioFire respiratory panel 2.1 plus and exploratory analysis of Ct values for respiratory pathogen quantification.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundsThe BioFire FilmArray RP2.1 plus is a syndromic multiplex PCR panel for qualitative detection of 20 respiratory pathogens. BioMérieux recently introduced FIREWORKS, a software platform providing access to amplification data, including cycle threshold (Ct) values.
objectivesThis study evaluated the diagnostic performance of the BioFire RP2.1 plus and explored the potential utility of Ct values for semi-quantitative assessment of pathogen load.
methodsThis retrospectively study included 72 specimens. Some were serially diluted for quantitative analyses, yielding 130 PCR tests. Samples were tested on the BioFire RP2.1 plus, and compared with Xpert, Xpress Cov-2/Flu/RSV plus (Cepheid) or in-house real-time PCR assays QuantStudio, resulting in 708 PCR results. Agreement was assessed qualitatively using the kappa coefficient, and exploratory analyses were performed using Passing-Bablok regression and Spearman correlation.
resultsThe BioFire RP2.1 plus demonstrated excellent qualitative agreement with comparator methods (kappa of 0.963). Among 130 tests, 117 were concordant. Nine discordant negatives involved Bordetella pertussis (n = 4), Coronavirus NL63 (n = 1), Influenza A (n = 2), and Influenza B (n = 2) predominantly in specimens with high Ct values (low pathogen load). Four samples were negative by QuantStudio but detected by BioFire RP2.1 plus. Exploratory quantitative analyses demonstrated strong correlations between BioFire Ct values and reference assays, with Spearman coefficients of 0.71 (QuantStudio) and 0.93 (Xpert).
conclusionsOverall the BioFire RP2.1 plus showed high qualitative agreement with routine assays for respiratory pathogens detection. Quantitative analyses suggested a reproducible relationship between BioFire-derived Ct values and comparator methods, although these findings should be interpreted cautiously given the exploratory design and methodological limitations of cross-platform comparisons.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.